Story
Electra Therapeutics IPO Poised to Price Above Midpoint on Strong Investor Demand
Electra Therapeutics Inc. is poised to price its initial public offering in the upper half of its marketed range, a sign of robust investor appetite for the biotechnology firm. The strong demand suggests the company could raise more capital than initially anticipated in its public market debut.
Strong Demand Signals Higher Pricing
According to a Bloomberg report on Thursday, the IPO is now expected to price within the upper portion of its $14 to $16 per share range. This is attributed to significant interest from both new and existing institutional investors, which has reportedly resulted in the offering being oversubscribed several times over.
The company is offering approximately 21.67 million shares. Pricing a deal above the midpoint often indicates institutional confidence in a company's valuation and future prospects, potentially setting a positive tone for its first day of trading.
Listing Details
AdElectra Therapeutics, which focuses on developing late-stage treatments for immune-mediated diseases and cancer, is scheduled to finalize its IPO price after the market closes on Thursday, September 17. The key details for the market debut include:
- Exchange: Nasdaq Global Select Market
- Ticker Symbol: ETRA
- Trading Begins: Friday, September 18
A syndicate of banks, including Jefferies Financial Group Inc., Toronto-Dominion Bank, Evercore Inc., and Cantor Fitzgerald, are managing the offering.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.